Skip to main content

A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs

Publication ,  Conference
Neumann, P; Berry, SR; Nadler, E; Evans, WC; Palmer, J; Bell, C; Strevel, E; Fang, H; Ubel, PA
Published in: JOURNAL OF CLINICAL ONCOLOGY
May 20, 2009

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2009

Volume

27

Issue

15

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Neumann, P., Berry, S. R., Nadler, E., Evans, W. C., Palmer, J., Bell, C., … Ubel, P. A. (2009). A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 27). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Neumann, P., S. R. Berry, E. Nadler, W. C. Evans, J. Palmer, C. Bell, E. Strevel, H. Fang, and P. A. Ubel. “A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 27. AMER SOC CLINICAL ONCOLOGY, 2009.
Neumann P, Berry SR, Nadler E, Evans WC, Palmer J, Bell C, et al. A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.
Neumann, P., et al. “A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs.” JOURNAL OF CLINICAL ONCOLOGY, vol. 27, no. 15, AMER SOC CLINICAL ONCOLOGY, 2009.
Neumann P, Berry SR, Nadler E, Evans WC, Palmer J, Bell C, Strevel E, Fang H, Ubel PA. A survey of US and Canadian oncologists' attitudes toward the cost, cost-effectiveness (CE), and reimbursement of cancer drugs. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2009.

Published In

JOURNAL OF CLINICAL ONCOLOGY

ISSN

0732-183X

Publication Date

May 20, 2009

Volume

27

Issue

15

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences